Suppr超能文献

早期起始与传统起始腹膜透析:中国队列研究的结局。

Early-start and conventional-start peritoneal dialysis: a Chinese cohort study on outcome.

机构信息

Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Nephrology Division, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

出版信息

Ren Fail. 2020 Nov;42(1):305-313. doi: 10.1080/0886022X.2020.1743310.

Abstract

Early-start peritoneal dialysis (PD) is an effective option for patients need unplanned dialysis. However, there are few studies on the long-term prognosis of early-start PD patients. In this retrospective study, 635 eligible patients from 1 March 1996 to 30 September 2016 were included, and divided into three groups according to the duration of break-in period: 3 days or less, 4-13 days and more than 14 days. Patients started PD within 2 weeks and after 2 weeks were defined as early-start and conventional-start, respectively. The primary outcome was all-cause mortality, and the secondary outcome measures were peritonitis free survival and technical survival. Mechanical and infectious complications in the first 180 days were also analyzed. Early-start PD patients were more likely to have higher serum total carbon dioxide and creatinine levels and lower serum albumin, Kt/v, creatinine clearance (Ccr) and residual glomerular filtration rate (rGFR) levels at the start of PD. The median follow-up period was 30 months (interquartile range, 13-53 months). A worse survival was observed in the early-start group than that in the conventional-start group ( < 0.001), even adjustment for the covariates (HR 1.549, 95%CI 1.104-2.173,  = 0.011). In the subgroup analysis, in patients commencing PD after 2006 early-start and conventional-start PD patients had comparable survival. No differences were observed in the rate of infectious and mechanical complications, peritonitis-free survival and technique survival between early-start and conventional-start PD patients. Early-start PD could be a safe and effective strategy for patients needing unplanned dialysis initiation with the progress of technology on PD.

摘要

早期开始腹膜透析(PD)是计划外透析患者的有效选择。然而,关于早期开始 PD 患者的长期预后的研究较少。在这项回顾性研究中,纳入了 1996 年 3 月 1 日至 2016 年 9 月 30 日期间的 635 名符合条件的患者,并根据导入期的持续时间分为三组:3 天或更短、4-13 天和 14 天以上。PD 开始后 2 周内和 2 周后开始 PD 的患者分别被定义为早期开始和常规开始。主要结局是全因死亡率,次要结局是腹膜炎无生存和技术生存。还分析了前 180 天的机械和感染并发症。早期开始 PD 患者的血清总二氧化碳和肌酐水平较高,血清白蛋白、Kt/v、肌酐清除率(Ccr)和残余肾小球滤过率(rGFR)水平较低。中位随访时间为 30 个月(四分位距 13-53 个月)。与常规开始组相比,早期开始组的生存状况较差( < 0.001),即使调整了协变量(HR 1.549,95%CI 1.104-2.173,  = 0.011)。在亚组分析中,在 2006 年后开始 PD 的患者中,早期开始和常规开始 PD 患者的生存情况相当。早期开始和常规开始 PD 患者的感染和机械并发症发生率、腹膜炎无生存和技术生存无差异。随着 PD 技术的进步,早期开始 PD 可能是计划外透析开始的患者的一种安全有效的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3768/7144326/0ba512e4726c/IRNF_A_1743310_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验